Literature DB >> 16995840

Creatine kinase activity in patients with diabetes mellitus type I and type II.

Adlija Jevrić-Causević1, Maja Malenica, Tanja Dujić.   

Abstract

Diabetes mellitus can be looked upon as an array of diseases, all of which exhibit common symptoms. While pathogenesis of IDDM (insulin dependant diabetes mellitus) is well understood, the same is not true for diabetes mellitus type II. In the latter case, relative contribution of the two factors (insulin resistance or decreased insulin secretion) varies individually, being highly increased in peripheral tissues and strictly dependant on insulin for glucose uptake. Moreover, in patients with diabetes mellitus type II, disbalance at the level of regulation of glucose metabolism as well as lipid metabolism has been noted in skeletal muscles. It is normal to assume that in this type of diabetes, these changes are reflected at the level of total activity of enzyme creatine kinase. This experimental work was performed on a group of 80 regular patients of Sarajevo General Hospital. Forty of those patients were classified as patients with diabetes type I and forty as patients with diabetes type II. Each group of patients was carefully chosen and constituted of equal number of males and females. The same was applied for adequate controls. Concentration of glucose was determined for each patient with GOD method, while activity of creatine kinase was determined with CK-NAC activated kit. Statistical analysis of the results was performed with SPSS software for Windows. Obtained results point out highly expressed differences in enzyme activity between two populations examined. Changes in enzyme activity are more expressed in patients with diabetes type II. Positive correlation between concentration of glucose and serum activity of the enzyme is seen in both categories of diabetic patients which is not the case for the patients in control group. At the same time, correlation between age and type of diabetes does exist . This is not followed at the level of enzyme activity or concentration of glucose.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16995840      PMCID: PMC7193654          DOI: 10.17305/bjbms.2006.3135

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  4 in total

1.  Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.

Authors:  J A Simoneau; D E Kelley
Journal:  J Appl Physiol (1985)       Date:  1997-07

2.  Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle.

Authors:  M Ponticos; Q L Lu; J E Morgan; D G Hardie; T A Partridge; D Carling
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

Review 3.  Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?

Authors:  Bret H Goodpaster; David E Kelley
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 4.  Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit.

Authors:  K D Gerbitz; K Gempel; D Brdiczka
Journal:  Diabetes       Date:  1996-02       Impact factor: 9.461

  4 in total
  3 in total

1.  Serum Creatine Kinase-MB Isoenzyme Activity among Subjects with Uncomplicated Essential Hypertension: Any Sex Differences.

Authors:  Mathias Abiodun Emokpae; Goodluck O N A Nwagbara
Journal:  Med Sci (Basel)       Date:  2017-04-27

Review 2.  New Era of Diacylglycerol Kinase, Phosphatidic Acid and Phosphatidic Acid-Binding Protein.

Authors:  Fumio Sakane; Fumi Hoshino; Chiaki Murakami
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

3.  Multi-target bioactivity of summer quinones production in the Persian Gulf burrowing black-type sea urchin.

Authors:  Soolmaz Soleimani; Sakineh Mashjoor; Morteza Yousefzadi; Manish Kumar
Journal:  Heliyon       Date:  2022-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.